“…These concentrations might be influenced by a variety of parameters, which can be divided into patient factors (female sex, age at surgery (young), time since implantation), implant factors (bilateral, small femoral HRA components, design, type of implant (HRA/LHMoM)) and surgical factors (acetabular component malposition, reduced contact patch to rim distance) [55]. There was a concern that increased cobalt and chromium ion concentrations increased the risk for cancer, but this was proven otherwise in large comparative studies [56,57]. Nevertheless, in 2012, the NetherlandsOrthopaedicAssociation (NOV) advised against the use of any MoM hip arthroplasty [58,59].…”